Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Woster

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Use of polyamine derivatives as selective histone deacetylase inhibitorsPatrick M Woster
ACS Medicinal Chemistry Letters|May 18, 2019
Citizenship in the World of Medicinal Chemistry: 25 Years as an ACSMEDI VolunteerPatrick M Woster
Journal of Medicinal Chemistry|December 4, 2009
Foreword: American Chemical Society Division of Medicinal Chemistry. Celebrating 100 years of excellencePatrick M Woster
Bioorganic & Medicinal Chemistry Letters|December 5, 2013
Design of small molecule epigenetic modulatorsBoobalan Pachaiyappan, Patrick M Woster
Medchemcomm|May 26, 2015
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding groupYouxuan Li, Patrick M Woster
ACS Medicinal Chemistry Letters|June 3, 2014
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1Isuru R Kumarasinghe, Patrick M Woster
Journal of Medicinal Chemistry|June 19, 2009
Recent advances in the development of polyamine analogues as antitumor agentsRobert A Casero, Patrick M Woster
European Journal of Medicinal Chemistry|February 21, 2018
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesisIsuru R Kumarasinghe, Patrick M Woster
Expert Reviews in Molecular Medicine|February 26, 2013
Polyamines and cancer: implications for chemotherapy and chemopreventionShannon L Nowotarski, Patrick M Woster, Robert A Casero
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 16, 2021
Inhibition of Polyamine Biosynthesis Using Difluoromethylornithine Acts as a Potent Immune Modulator and Displays Therapeutic Synergy With PD-1-blockadeParker Dryja, Carrie Fisher, Patrick M Woster, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Use of polyamine derivatives as selective histone deacetylase inhibitorsPatrick M Woster
ACS Medicinal Chemistry Letters|May 18, 2019
Citizenship in the World of Medicinal Chemistry: 25 Years as an ACSMEDI VolunteerPatrick M Woster
Journal of Medicinal Chemistry|December 4, 2009
Foreword: American Chemical Society Division of Medicinal Chemistry. Celebrating 100 years of excellencePatrick M Woster
Bioorganic & Medicinal Chemistry Letters|December 5, 2013
Design of small molecule epigenetic modulatorsBoobalan Pachaiyappan, Patrick M Woster
Medchemcomm|May 26, 2015
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding groupYouxuan Li, Patrick M Woster
ACS Medicinal Chemistry Letters|June 3, 2014
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1Isuru R Kumarasinghe, Patrick M Woster
Journal of Medicinal Chemistry|June 19, 2009
Recent advances in the development of polyamine analogues as antitumor agentsRobert A Casero, Patrick M Woster
European Journal of Medicinal Chemistry|February 21, 2018
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesisIsuru R Kumarasinghe, Patrick M Woster
Expert Reviews in Molecular Medicine|February 26, 2013
Polyamines and cancer: implications for chemotherapy and chemopreventionShannon L Nowotarski, Patrick M Woster, Robert A Casero
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 16, 2021
Inhibition of Polyamine Biosynthesis Using Difluoromethylornithine Acts as a Potent Immune Modulator and Displays Therapeutic Synergy With PD-1-blockadeParker Dryja, Carrie Fisher, Patrick M Woster, et al.
Pageof 9